Clinical Trial

To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of inhaled corticosteroids combined with bronchodilators and programmed death-ligand 1 (PD-L1) inhibitor plus platinum-based chemotherapy in patients with advanced lung squamous cell carcinoma complicated with chronic obstructive pulmonary disease (COPD)
Trial Details
NCT Number NCT06772454
Lead Sponsor Guangzhou Institute of Respiratory Disease
Conditions Lung Cancer Squamous Cell, COPD
Enrollment 60 participants
Start Date 2023-01-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-13